These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4436936)

  • 1. Plasma aldosterone in essential hypertension with low renin activity.
    Fukuchi S; Nakajima K; Takenouchi T; Nishisato K
    Jpn Circ J; 1974 Dec; 38(12):1071-7. PubMed ID: 4436936
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppressed plasma renin activity in in hypertensive patients--its evaluation for the diagnosis of primary aldosteronism.
    Maebashi M; Yoshinaga K; Miura K; Goto K; Katsushima I
    Tohoku J Exp Med; 1969 Dec; 99(4):393-405. PubMed ID: 5371269
    [No Abstract]   [Full Text] [Related]  

  • 3. Low-renin hypertension. Restoration of normotension and renin responsiveness.
    Spark RF; O'Hare CM; Regan RM
    Arch Intern Med; 1974 Feb; 133(2):205-11. PubMed ID: 4591266
    [No Abstract]   [Full Text] [Related]  

  • 4. Diuretic therapies in low renin and normal renin essential hypertension.
    Brooks CS; Johnson CA; Kotchen JM; Kotchen TA
    Clin Pharmacol Ther; 1977 Jul; 22(1):14-20. PubMed ID: 326459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Spironolactone and thiabutazide in the treatment of essential hypertension (author's transl)].
    Klump F; Braun B; Klaus D; Lemke R; Zehner J; Zöfel P
    Dtsch Med Wochenschr; 1975 Mar; 100(12):577-84. PubMed ID: 1168122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Plasma aldosterone and plasma renin activity in patients with essential and renal hypertension under acute stimulation with saline depletion and acute suppression with saline infusion].
    Klumpp F; Klaus D; Lemke R; Zehner J; Zöfel P
    Klin Wochenschr; 1975 Mar; 53(5):221-9. PubMed ID: 1152349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of furosemide administration and upright position on plasma renin activity and angiotensin II in hypertension.
    Fukuchi S; Takenouchi T; Nakajima K
    Tohoku J Exp Med; 1973 Sep; 111(1):71-8. PubMed ID: 4359911
    [No Abstract]   [Full Text] [Related]  

  • 8. Reduced response of plasma aldosterone to acute ACTH stimulation during long-term treatment with spironolactone in essential hypertension.
    Kim KS; Morimoto S; Uchida K; Miyamori I; Miyamoto M; Takeda R
    Horm Res; 1979; 11(1):4-11. PubMed ID: 225255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of saralasin on plasma aldosterone in hypertensive man.
    Brown RD; Tucker R; Tue K; Wisgerhof M; Salassa R
    J Lab Clin Med; 1978 Mar; 91(3):473-9. PubMed ID: 627750
    [No Abstract]   [Full Text] [Related]  

  • 10. Similar effects of hydrochlorothiazide and spironolactone on plasma renin activity in essential hypertension.
    Acchiardo S; Dustan HP; Tarazi RC
    Cleve Clin Q; 1972; 39(4):153-62. PubMed ID: 4660197
    [No Abstract]   [Full Text] [Related]  

  • 11. Dissociation between renin and aldosterone during chronic diuretic therapy. Effect of the addition of a beta blocker, timolol.
    Lebel M; Grose JH; Belleau LJ
    J Clin Pharmacol; 1979; 19(8-9 Pt 1):424-7. PubMed ID: 489761
    [No Abstract]   [Full Text] [Related]  

  • 12. Rapid increase of mineralocorticoids after furosemide in low-renin essential hypertension: evidence for 18-hydroxycorticosterone to be a better marker than aldosterone.
    Witzgall H; Thayil G; Weber PC
    Klin Wochenschr; 1982 Aug; 60(16):847-52. PubMed ID: 6752560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The constant plasma 18-hydroxycorticosterone to aldosterone ratio: an expression of the efficacy of corticosterone methyloxidase type II activity in disorders with variable aldosterone production.
    Kater CE; Biglieri EG; Rost CR; Schambelan M; Hirai J; Chang BC; Brust N
    J Clin Endocrinol Metab; 1985 Feb; 60(2):225-8. PubMed ID: 2981240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of low-renin essential hypertension. Comparison of spironolactone and a hydrochlorothiazide-triamterene combination.
    Douglas JG; Hollifield JW; Liddle GW
    JAMA; 1974 Feb; 227(5):518-21. PubMed ID: 4589187
    [No Abstract]   [Full Text] [Related]  

  • 15. Spironolactone and hydrochlorothiazide in normal-renin and low-renin essential hypertension.
    Ferguson RK; Turek DM; Rovner DR
    Clin Pharmacol Ther; 1977 Jan; 21(1):62-9. PubMed ID: 318952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in plasma renin activity after administration of spironolactone.
    Maebashi M; Yoshinaga K
    Jpn Circ J; 1967 Mar; 31(3):435-9. PubMed ID: 6072372
    [No Abstract]   [Full Text] [Related]  

  • 17. Low renin essential hypertension in a child.
    Leumann EP; Nussberger J; Vetter W
    Helv Paediatr Acta; 1976 Jan; 30(4-5):357-63. PubMed ID: 1245435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of spironolactone in hypertensive patients on regular haemodialysis and after renal allotransplantation.
    Papadimitriou M; Vyzantiadis A; Milionis A; Memmos D; Metaxas P
    Life Support Syst; 1983; 1(3):197-205. PubMed ID: 6433115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive effect of spironolactone in essential, renal and mineralocorticoid hypertension.
    Mantero F; Armanini D; Urbani S
    Clin Sci Mol Med Suppl; 1973 Aug; 45 Suppl 1():219s-24. PubMed ID: 4522169
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma concentration of aldosterone, 18-hydroxy-deoxycorticosterone and cortisol in adrenal veins of patients with low-renin hypertension.
    Horký K; Gregorová I; Tomsová Z; Vancura J; Silinková-Málková E
    Horm Metab Res; 1977 Sep; 9(5):403-9. PubMed ID: 200537
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.